跳到正文
原文
独立行政法人 医薬品医療機器総合機構(PMDA)· @PMDA_JPN · X·· 12 天前精选AI 评分62
AI 导读

PMDA发布《监管活动中使用AI的基本原则(早期考量)》,旨在推动AI在医药产品全生命周期中的负责任使用与开发。该文件已在其官网英文页面公布。

推荐理由

PMDA发布AI用于监管活动的基本原则,读者可了解日本监管机构对AI在医药产品全生命周期应用的立场。

正文

[Notice: #EarlyConsideration has been published]
Using AI for better healthcare.
We have published our “Basic Principles for the Use of AI in Regulatory Activities (Early Consideration)” to promote the responsible use and development of AI throughout the lifecycle of medical products.
https://www.pmda.go.jp/english/review-services/regulatory-info/0005.html

来源:独立行政法人 医薬品医療機器総合機構(PMDA) · x.com